Member list of California Life Sciences Association

Below you find a list of all members of CLSA in alphabetical order.

Results 81 - 100 out of 950 displayed.
 
Sort direction:
Sort direction:
«  1  2  3  4 5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48 »
Aragen Life Sciences   
Morgan Hill, USA
Aragen, a CRO, is a R&D and manufacturing partner to the life sciences industry. The company support every stage of the biopharma lifecycle, in small and large molecules. Aragen offers discovery solutions, drug substance, drug product and analytical solutions to customers entering or advancing through clinical development.
Arcadia Biosciences   
Dallas, USA
Arcadia Biosciences, Inc. is an agricultural food ingredient company that develops and commercializes health and nutrition ingredient traits. The company is a producer of plant-based health and wellness products, including Agronomic Wheat Traits and Zola® coconut water.
Arcus Biosciences, Inc.   
Hayward, USA
Arcus Biosciences Inc. is a clinical-stage biopharmaceutical company. The company develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment, to create and optimize differentiated small-molecule immuno-oncology product candidates. The company's product pipeline includes Domvanalimab, Etrumadenant, AB598, and Casdatifan, among others. Arcus conducts clinical trials for different...
Ardelyx, Inc.   
Waltham, USA
Ardelyx is a clinical-stage biopharmaceutical company that discovers, develops and commercializes innovative, first-in-class medicines that meet significant unmet medical needs. Ardelyx has two commercial products approved in the United States, Ibsrela® (tenapanor) and Xphozah® (tenapanor). The company offers a platform that enables the discovery of new biological mechanisms and pathways to create oral and small molecule therapies. .
Aridis Pharmaceuticals Inc.   
Los Gatos, USA
Aridis Pharmaceuticals is a clinical development company that creates transformative, first-in-class anti-infectives for life-threatening respiratory infections. The company’s pipeline of novel mechanism antibacterial and antivirals, sprung from its proprietary technology platforms, are designed to combat the growing public health threat of antimicrobial resistant bacteria (AMR). The company’s proprietary technology platforms, ⅄PEX and MabIgX®, can identify human-derived monoclonal antibodies...
ARIEL Precision Medicine, Inc.   
Pittsburgh, USA
Ariel is a precision medicine company, transforming genetic and clinical data into new insights for the diagnosis, management and advanced therapeutic development for complex health conditions.
Arima Genomics, Inc.   
San Diego, USA
Arima Genomics, Inc. is a biotechnology company that aims to accelerate the understanding of spatial genomics toward discovery, diagnosis and therapy. The company's Arima Hi-C is a proximity ligation method that captures the organizational structure of chromatin in three dimensions, where genomic sequences that are distal to each other in linear distance can be closer to each other in the 3D space.
ARIZ Precision Medicine   
Davis, USA
ARIZ Precision Medicine is a biotechnology company focused on developing precision medicines for cancer. The company combines targeted therapeutics with nanotechnology-based drug delivery and gene- and protein-modifying approaches to selectively target cancer-driving proteins while minimizing damage to normal cells. The company pipeline consists of targeted small-molecule drug candidates designed to inhibit specific molecular drivers of cancer and advance through preclinical development for...
Arnold & Porter Kaye Scholer LLP   
San Fransisco, USA
Arnold & Porter is a firm of lawyers, providing sophisticated litigation and transactional capabilities, renowned regulatory experience and multidisciplinary practices in the life sciences and financial services industries.
Arsenal Biosciences, Inc.   
South San Francisco, USA
ArsenalBio is a clinical-stage biotechnology company developing programmable cell therapies, primarily engineered T-cell/CAR T-cell therapies, for the treatment of solid tumors. The company uses synthetic biology, computational approaches, and CRISPR-based genetic engineering to program T cells with multiple therapeutic functions intended to improve tumor targeting, activity, persistence, and safety.
Artelo Biosciences, Inc.   
Solana Beach, USA
Artelo Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies that modulate lipid-signaling pathways, including the endocannabinoid system. The company is developing a pipeline of proprietary cannabinoid-based and other lipid-signaling therapeutics targeting serious diseases, with programs focused on cancer-related conditions, anorexia and anxiety.
Ascella Biosystems   
San Francisco, USA
Ascella Biosystems is an early stage diagnostics company focused on the development and commercialization of a rapid handheld viral molecular RNA testing system. The company's RAIL™ technology offers sensitivity and specificity comparable to PCR. The features of company's products include, molecular detection, quick results, affordable, variant identification, handheld and parallel detection.
Ascendis Pharma, Inc.   
Palo Alto, USA
Ascendis Pharma is a pharmaceutical company that develops improved, patentable versions of high-value drugs. The company’s proprietary TransCon technology is used to generate drug candidates that are more effective and have lower risk.
AscentX Medical, Inc.   
San Diego, USA
AscentX Medical is a privately held medical technology company focused on the clinical development and marketing of novel, minimal-invasive endoscopic injection procedures designed to address unmet medical needs amongst both patients and physicians and help cure various debilitating and socially isolating medical conditions of the growing aging population. The company's primary focus is on the clinical testing of G125, specifically developed as a curative treatment for GERD.
Ashvattha Therapeutics, LLC   
Redwood City, USA
Ashvattha Therapeutics is a clinical-stage biotechnology company developing a new class of precision nanomedicine therapeutics designed to selectively target and reprogram activated cells in regions of inflammation. The company's platform is based on proprietary hydroxyl dendrimer therapeutics (HDTs) that can traverse biological barriers such as the blood-brain and blood-retinal barriers to deliver drugs directly to diseased tissues with high precision. Ashvattha Therapeutics pipeline includes...
Aspen Neuroscience, Inc   
San Diego, USA
Aspen Neuroscience, Inc. is a company developing personalized autologous induced pluripotent stem cell (iPSC)-derived cell therapies for neurological disorders, initially focusing on Parkinson’s disease. The company’s lead investigational therapy, sasineprocel (ANPD001), is an autologous dopaminergic neuronal precursor cell therapy designed to replace lost dopamine-producing neurons and restore neural function. Aspen’s platform combines stem cell biology, genomics, bioinformatics and machine...
Assembly Biosciences, Inc.   
South San Francisco, USA
Assembly Biosciences is a biotechnology company dedicated to the development of innovative small-molecule therapeutics designed to change the path of serious viral and liver diseases and improve the lives of patients worldwide. Led by an accomplished team of leaders in viral and liver diseases, Assembly Bio is committed to improving outcomes for patients struggling with the serious, chronic impacts of herpesvirus, hepatitis delta virus (HDV) infections, cholestatic liver diseases and hepatitis...
Astraea Therapeutics LLC   
Mountain View, USA
Astraea Therapeutics is a privately-held biopharmaceutical company. The company is specializing in novel approaches, with small-molecule therapeutics, for the treatment of drug addiction and central nervous system disorders, including pain and neurodegenerative diseases.
Atara Biotherapeutics, Inc.   
Thousand Oaks, USA
Atara Biotherapeutics, Inc. is a T-cell immunotherapy company leveraging the allogeneic EBV T-cell platform to develop transformative therapies for patients with serious diseases including solid tumors, hematologic cancers and autoimmune disease. The company's product Tabelecleucel (tab-cel®) is being developed for relapsed or refractory EBV-positive post-transplant lymphoproliferative disease (PTLD), an ultra-rare and aggressive hematologic cancer. The company's other products in the pipeline...
Atgenomix Inc   
Taipei City, Taiwan
Atgenomix is a data and machine learning company focused on biomedical data management and analysis for precision medicine applications. The company develops cloud-based platforms and software solutions that support large-scale processing, integration, and analysis of genomic and multi-omics data. Its technologies are used by next-generation sequencing (NGS) testing providers, clinical researchers, and bioinformatics developers to enable clinical diagnostics, research workflows, and deployment...

«  1  2  3  4 5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48 »

Disclaimer: Any membership totals displayed reflect organizations who have agreed to display their membership information and may not be indicative of CLSA's total member population.

© Biotechgate by Venture Valuation